Immune system treatment to reduce stress can prevent cancer metastases, study explains

A new approach from Tel Aviv University can save the lives of cancer patients! Researchers have found that the short time period around tumour removal surgery (the weeks before and after surgery) is critical for the prevention of metastases development, which develops when the body is under stress.

ANI | Tel Aviv | Updated: 23-07-2020 10:07 IST | Created: 23-07-2020 10:07 IST
Immune system treatment to reduce stress can prevent cancer metastases, study explains
Representative Image . Image Credit: ANI

A new approach from Tel Aviv University can save the lives of cancer patients! Researchers have found that the short time period around tumour removal surgery (the weeks before and after surgery) is critical for the prevention of metastases development, which develops when the body is under stress. According to the University researchers, patients require immunotherapeutic treatment as well as treatment to reduce inflammation and physical and psychological stress. The research was conducted by Prof. Shamgar Ben-Eliyahu of TAU's School of Psychological Sciences and Sagol School of Neuroscience and Prof. Oded Zmora from Assaf Harofe Medical Center.

The research results were published in the journal Cancer. Immunotherapeutic treatment is a medical treatment that activates the immune system. One such treatment is the injection of substances with similar receptors to those of viruses and bacteria into the patient's body. The immune system recognizes them as a threat and activates itself, thus preventing metastatic disease.

Prof. Ben-Eliyahu explains that surgery for the removal of the primary tumour is a mainstay in cancer treatment. But the risk of developing metastases after surgery is estimated at 10 per cent among breast cancer patients, at 20-40 per cent among colorectal cancer patients, and at 80 per cent among pancreatic cancer patients. According to Prof. Ben-Eliyahu, when the body is under physiological or psychological stress such as surgery, groups of hormones called prostaglandin and catecholamine are produced in large quantities. These hormones suppress the immune system cells' activity and indirectly increase the development of metastases.

Additionally, these hormones help tumour cells left after the surgery to develop into life-threatening metastases. Exposure to those hormones causes tumour tissues to become more aggressive and metastatic. "Medical and immunotherapeutic intervention to reduce psychological and physiological stress and activate the immune system in the critical period before and after the surgery can prevent the development of metastases, which will be discovered months or years later," Prof. Ben-Eliyahu said.

Prof. Ben-Eliyahu added that anti-metastatic treatment today skips the critical period around the surgery, leaving the medical staff to face the consequences of treating progressive and resistant metastatic processes, which are much harder to stop. Prof. Ben-Eliyahu's research contradicts the assumption, widespread in the medical community, that immunotherapeutic treatment for cancer patients in the month before and after the surgery is not recommended. (ANI)

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

World Water Day sees crises of inequality in countries both rich and poor

... ...

Videos

Latest News

Chad President Idriss Deby dies on frontlines, army spokesman says

Chads President Idriss Deby has died while visiting troops on the frontline of a fight against northern rebels, an army spokesman said on Tuesday, the day after Deby was declared the winner of a presidential election. Deby, 68, came to powe...

Rahul Gandhi tests positive for COVID-19

Congress leader Rahul Gandhi on Tuesday said he has tested positive for COVID-19 and has mild symptoms.After experiencing mild symptoms, Ive just tested positive for COVID, the 50-year-old posted on Twitter.All those whove been in contact w...

US STOCKS-Futures slip as focus shifts to earnings from tech-related firms

U.S. stock index futures dipped on Tuesday as investors turned to results from Netflix and other major technology-related companies this week to sustain the positive start to the earnings season.Streaming service provider Netflix that thriv...

Military: Chadian president killed after 30 years in power

Chadian President Idriss Deby Itno, who ruled the central African nation for more than three decades, was killed Tuesday on the battlefield in a fight against rebels, the countrys top military commander announced on national television and ...

Give Feedback